Published in Circ Res on May 05, 2011
Cardiac Stem Cell Infusion in Patients With Ischemic CardiOmyopathy (SCIPIO) (SCIPIO) | NCT00474461
Concern Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial. Lancet (2011) 11.45
Administration of cardiac stem cells in patients with ischemic cardiomyopathy: the SCIPIO trial: surgical aspects and interim analysis of myocardial function and viability by magnetic resonance. Circulation (2012) 2.83
Growth properties of cardiac stem cells are a novel biomarker of patients' outcome after coronary bypass surgery. Circulation (2013) 2.19
Interleukin-10 deficiency impairs bone marrow-derived endothelial progenitor cell survival and function in ischemic myocardium. Circ Res (2011) 1.99
Regenerating new heart with stem cells. J Clin Invest (2013) 1.83
Tracking chromatid segregation to identify human cardiac stem cells that regenerate extensively the infarcted myocardium. Circ Res (2012) 1.63
Notch signaling mediates the age-associated decrease in adhesion of germline stem cells to the niche. PLoS Genet (2014) 1.44
The emerging role of IGF-1 deficiency in cardiovascular aging: recent advances. J Gerontol A Biol Sci Med Sci (2012) 1.14
Wnt signaling exerts an antiproliferative effect on adult cardiac progenitor cells through IGFBP3. Circ Res (2011) 1.13
Concise review: heart regeneration and the role of cardiac stem cells. Stem Cells Transl Med (2013) 1.08
Protein O-GlcNAcylation is a novel cytoprotective signal in cardiac stem cells. Stem Cells (2013) 0.99
Increased mitotic rate coincident with transient telomere lengthening resulting from pim-1 overexpression in cardiac progenitor cells. Stem Cells (2012) 0.96
The key role of insulin-like growth factor I in limbal stem cell differentiation and the corneal wound-healing process. Stem Cells Dev (2012) 0.94
Testosterone Antagonizes Doxorubicin-Induced Senescence of Cardiomyocytes. J Am Heart Assoc (2016) 0.91
Making it stick: chasing the optimal stem cells for cardiac regeneration. Expert Rev Cardiovasc Ther (2014) 0.91
Origin of cardiomyocytes in the adult heart. Circ Res (2015) 0.89
Innate regeneration in the aging heart: healing from within. Mayo Clin Proc (2013) 0.89
Intramuscular VEGF activates an SDF1-dependent progenitor cell cascade and an SDF1-independent muscle paracrine cascade for cardiac repair. Am J Physiol Heart Circ Physiol (2011) 0.87
Integrative Analysis of the Developing Postnatal Mouse Heart Transcriptome. PLoS One (2015) 0.85
The existence of myocardial repair: mechanistic insights and enhancements. Cardiol Rev (2013) 0.82
Enhancing the potential of cardiac progenitor cells: pushing forward with Pim-1. Circ Res (2012) 0.82
Cardiac stem cells: biology and clinical applications. Antioxid Redox Signal (2014) 0.80
Human neonatal cardiovascular progenitors: unlocking the secret to regenerative ability. PLoS One (2013) 0.80
The mircrine mechanism controlling cardiac stem cell fate. Front Genet (2013) 0.79
Local activation of cardiac stem cells for post-myocardial infarction cardiac repair. J Cell Mol Med (2012) 0.79
Predicting the future with stem cells. Circulation (2013) 0.79
Cardiac aging - Getting to the stem of the problem. J Mol Cell Cardiol (2015) 0.78
Characterization of superoxide dismutases in cardiac progenitor cells demonstrates a critical role for manganese superoxide dismutase. Stem Cells Dev (2012) 0.78
Endogenous cardiac stem cells for the treatment of heart failure. Stem Cells Cloning (2013) 0.78
Modulation of Human Cardiac Progenitors via Hypoxia-ERK Circuit Improves their Functional Bioactivities. Biomol Ther (Seoul) (2013) 0.77
Myocyte renewal and therapeutic myocardial regeneration using various progenitor cells. Heart Fail Rev (2014) 0.77
Doxorubicin impairs the insulin-like growth factor-1 system and causes insulin-like growth factor-1 resistance in cardiomyocytes. PLoS One (2015) 0.77
Stimulating endogenous cardiac repair. Front Cell Dev Biol (2015) 0.76
Stem cell therapy for cardiovascular disease: the demise of alchemy and rise of pharmacology. Br J Pharmacol (2013) 0.76
Cellular and molecular characterization of human cardiac stem cells reveals key features essential for their function and safety. Stem Cells Dev (2015) 0.75
Rho-Associated Kinase Inhibitor (Y-27632) Attenuates Doxorubicin-Induced Apoptosis of Human Cardiac Stem Cells. PLoS One (2015) 0.75
A Novel Class of Human Cardiac Stem Cells. Cardiol Rev (2015) 0.75
Stem Cell Therapy for the Heart: Blind Alley or Magic Bullet? J Cardiovasc Transl Res (2016) 0.75
How do resident stem cells repair the damaged myocardium? World J Stem Cells (2015) 0.75
Bmi1 and BRG1 drive myocardial repair by regulating cardiac stem cell function in acute rheumatic heart disease. Exp Ther Med (2017) 0.75
Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell (2003) 18.09
The plasticity of aging: insights from long-lived mutants. Cell (2005) 9.88
Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens. Circulation (2007) 8.62
Human cardiac stem cells. Proc Natl Acad Sci U S A (2007) 7.76
Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis. Arch Intern Med (2007) 6.68
Mannose 6-phosphate receptors: new twists in the tale. Nat Rev Mol Cell Biol (2003) 4.72
Stem cell niches in the adult mouse heart. Proc Natl Acad Sci U S A (2006) 4.58
Cardiac stem cell and myocyte aging, heart failure, and insulin-like growth factor-1 overexpression. Circ Res (2004) 4.13
Myocardial regeneration by activation of multipotent cardiac stem cells in ischemic heart failure. Proc Natl Acad Sci U S A (2005) 3.93
Controversies in ventricular remodelling. Lancet (2006) 3.39
Local activation or implantation of cardiac progenitor cells rescues scarred infarcted myocardium improving cardiac function. Circ Res (2008) 3.07
Effects of telomerase and telomere length on epidermal stem cell behavior. Science (2005) 3.05
New ways not to make ends meet: telomerase, DNA damage proteins and heterochromatin. Oncogene (2002) 2.46
Structure and autoregulation of the insulin-like growth factor 1 receptor kinase. Nat Struct Biol (2001) 2.45
Senescence and death of primitive cells and myocytes lead to premature cardiac aging and heart failure. Circ Res (2003) 2.45
Activation of cardiac progenitor cells reverses the failing heart senescent phenotype and prolongs lifespan. Circ Res (2008) 2.31
Cardiac progenitor cells and biotinylated insulin-like growth factor-1 nanofibers improve endogenous and exogenous myocardial regeneration after infarction. Circulation (2009) 2.30
The Rac and Rho hall of fame: a decade of hypertrophic signaling hits. Circ Res (2006) 2.29
Identification of a coronary vascular progenitor cell in the human heart. Proc Natl Acad Sci U S A (2009) 2.23
IGF-1 overexpression inhibits the development of diabetic cardiomyopathy and angiotensin II-mediated oxidative stress. Diabetes (2001) 1.92
Regulatory factors and cell populations involved in skeletal muscle regeneration. J Cell Physiol (2010) 1.83
IGFBP-4 is an inhibitor of canonical Wnt signalling required for cardiogenesis. Nature (2008) 1.77
Stretch-mediated release of angiotensin II induces myocyte apoptosis by activating p53 that enhances the local renin-angiotensin system and decreases the Bcl-2-to-Bax protein ratio in the cell. J Clin Invest (1998) 1.73
Cardiac regeneration. J Am Coll Cardiol (2006) 1.67
Mechanism of telomere shortening by oxidative stress. Ann N Y Acad Sci (2004) 1.61
Insulin-like growth factor 2 (IGF-2) potentiates BMP-9-induced osteogenic differentiation and bone formation. J Bone Miner Res (2010) 1.58
IGF-II transcription in skeletal myogenesis is controlled by mTOR and nutrients. J Cell Biol (2003) 1.56
The contradictions of the insulin-like growth factor 1 receptor. Oncogene (2000) 1.52
Structural determinants for high-affinity binding of insulin-like growth factor II to insulin receptor (IR)-A, the exon 11 minus isoform of the IR. Mol Endocrinol (2004) 1.44
Control of MyoD function during initiation of muscle differentiation by an autocrine signaling pathway activated by insulin-like growth factor-II. J Biol Chem (2006) 1.27
Type I insulin-like growth factor receptor signaling in skeletal muscle regeneration and hypertrophy. J Musculoskelet Neuronal Interact (2007) 1.26
Activated IGF-1R inhibits hyperglycemia-induced DNA damage and promotes DNA repair by homologous recombination. Am J Physiol Renal Physiol (2005) 1.21
Insulin-like growth factor actions during development of neural stem cells and progenitors in the central nervous system. J Neurosci Res (2006) 1.04
Akt signaling and growth of the heart. Circulation (2006) 1.03
Regulation of insulin-like growth factor (IGF) I receptor expression during muscle cell differentiation. Potential autocrine role of IGF-II. J Clin Invest (1991) 0.97
Role of the activation loop tyrosines in regulation of the insulin-like growth factor I receptor-tyrosine kinase. J Biol Chem (2006) 0.96
Stretch-induced hypertrophy of isolated adult rabbit cardiomyocytes. Am J Physiol Heart Circ Physiol (2010) 0.93
Regulation of proliferation and apoptosis by the insulin-like growth factor I receptor. Growth Horm IGF Res (2000) 0.87
An analysis of the effects of stretch on IGF-I secretion from rat ventricular fibroblasts. Am J Physiol Heart Circ Physiol (2007) 0.86
Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell (2003) 18.09
Concern Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial. Lancet (2011) 11.45
Chimerism of the transplanted heart. N Engl J Med (2002) 8.69
Human cardiac stem cells. Proc Natl Acad Sci U S A (2007) 7.76
Coronary bypass surgery with or without surgical ventricular reconstruction. N Engl J Med (2009) 7.71
Surgical treatment of moderate ischemic mitral regurgitation. N Engl J Med (2014) 7.23
Myocardial viability and survival in ischemic left ventricular dysfunction. N Engl J Med (2011) 6.65
Mitral-valve repair versus replacement for severe ischemic mitral regurgitation. N Engl J Med (2013) 6.21
Evidence for human lung stem cells. N Engl J Med (2011) 5.67
Osteoclasts degrade endosteal components and promote mobilization of hematopoietic progenitor cells. Nat Med (2006) 5.33
Surgical ablation of atrial fibrillation during mitral-valve surgery. N Engl J Med (2015) 4.77
Stem cell niches in the adult mouse heart. Proc Natl Acad Sci U S A (2006) 4.58
Cardiac stem cell and myocyte aging, heart failure, and insulin-like growth factor-1 overexpression. Circ Res (2004) 4.13
Stem cells in the dog heart are self-renewing, clonogenic, and multipotent and regenerate infarcted myocardium, improving cardiac function. Proc Natl Acad Sci U S A (2005) 4.13
Cardiac stem cells possess growth factor-receptor systems that after activation regenerate the infarcted myocardium, improving ventricular function and long-term survival. Circ Res (2005) 3.93
Myocardial regeneration by activation of multipotent cardiac stem cells in ischemic heart failure. Proc Natl Acad Sci U S A (2005) 3.93
Cardiac stem cells delivered intravascularly traverse the vessel barrier, regenerate infarcted myocardium, and improve cardiac function. Proc Natl Acad Sci U S A (2005) 3.64
Intracoronary administration of cardiac progenitor cells alleviates left ventricular dysfunction in rats with a 30-day-old infarction. Circulation (2010) 3.42
Bone marrow cells differentiate in cardiac cell lineages after infarction independently of cell fusion. Circ Res (2004) 3.39
Blood transfusion and infection after cardiac surgery. Ann Thorac Surg (2013) 3.35
Cardiac stem cells and mechanisms of myocardial regeneration. Physiol Rev (2005) 3.30
Two-Year Outcomes of Surgical Treatment of Severe Ischemic Mitral Regurgitation. N Engl J Med (2015) 3.11
Local activation or implantation of cardiac progenitor cells rescues scarred infarcted myocardium improving cardiac function. Circ Res (2008) 3.07
Bone marrow cells adopt the cardiomyogenic fate in vivo. Proc Natl Acad Sci U S A (2007) 3.06
Intense myocyte formation from cardiac stem cells in human cardiac hypertrophy. Proc Natl Acad Sci U S A (2003) 2.95
Nuclear targeting of Akt enhances kinase activity and survival of cardiomyocytes. Circ Res (2004) 2.91
HGF, SDF-1, and MMP-9 are involved in stress-induced human CD34+ stem cell recruitment to the liver. J Clin Invest (2003) 2.89
CD44 and hyaluronic acid cooperate with SDF-1 in the trafficking of human CD34+ stem/progenitor cells to bone marrow. Blood (2004) 2.84
Administration of cardiac stem cells in patients with ischemic cardiomyopathy: the SCIPIO trial: surgical aspects and interim analysis of myocardial function and viability by magnetic resonance. Circulation (2012) 2.83
Cardiomyogenesis in the adult human heart. Circ Res (2010) 2.79
Myocyte turnover in the aging human heart. Circ Res (2010) 2.77